Fortress Biotech, Inc. Shareholders' Equity
Fortress Biotech, Inc. (FBIO) had Shareholders' Equity of $164.14 million as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet › Equity › Equity, Including Portion Attributable to Noncontrolling Interest › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2026-08-13
- 2026-06-30: Stockholders' Equity Attributable to Parent $164.14M.
- 2026-03-31: Stockholders' Equity Attributable to Parent $162.21M.
- 2025-12-31: Stockholders' Equity Attributable to Parent $49.87M.
- 2025-09-30: Stockholders' Equity Attributable to Parent $55.86M.
| Period end | Stockholders' Equity Attributable to Parent | Stockholders' Equity Attributable to Parent as first filed |
|---|---|---|
| 2026-06-30 | $164.14M 10-Q · filed 2026-08-13 | |
| 2026-03-31 | $162.21M 10-Q · filed 2026-05-14 | |
| 2025-12-31 | $49.87M 10-Q · filed 2026-08-13 | |
| 2025-09-30 | $55.86M 10-Q · filed 2025-11-14 | |
| 2025-06-30 | $43.92M 10-Q · filed 2025-08-14 | |
| 2025-03-31 | $22.25M 10-Q · filed 2025-05-15 | |
| 2024-12-31 | $22.74M 10-K · filed 2026-03-31 | |
| 2024-09-30 | $21.16M 10-Q · filed 2024-11-14 | |
| 2024-06-30 | $17.88M 10-Q · filed 2024-08-13 | |
| 2024-03-31 | $23.02M 10-Q · filed 2024-05-15 | |
| 2023-12-31 | $22.54M 10-K · filed 2025-03-31 | |
| 2023-09-30 | $16.67M 10-Q · filed 2023-11-14 | |
| 2023-06-30 | $18.51M 10-Q · filed 2023-08-14 | |
| 2023-03-31 | $37.80M 10-Q · filed 2023-05-15 | |
| 2022-12-31 | $41.72M 10-K · filed 2024-03-28 | |
| 2022-09-30 | $61.67M 10-Q · filed 2022-11-14 | |
| 2022-06-30 | $77.22M 10-Q · filed 2022-08-11 | |
| 2022-03-31 | $97.86M 10-Q · filed 2022-05-12 | |
| 2021-12-31 | $108.67M 10-K · filed 2023-03-31 | |
| 2021-09-30 | $92.66M 10-Q · filed 2021-11-15 | |
| 2021-06-30 | $108.28M 10-Q · filed 2021-08-16 | |
| 2021-03-31 | $105.90M 10-Q · filed 2021-05-17 | |
| 2020-12-31 | $100.34M 10-K · filed 2022-03-28 | |
| 2020-09-30 | $97.11M 10-Q · filed 2020-11-09 | |
| 2020-06-30 | $60.48M 10-Q · filed 2020-08-10 | |
| 2020-03-31 | $37.23M 10-Q · filed 2020-05-11 | |
| 2019-12-31 | $26.21M 10-K/A · filed 2021-04-09 | |
| 2019-09-30 | $25.80M 10-Q · filed 2019-11-12 | |
| 2019-06-30 | $31.87M 10-Q · filed 2019-08-09 | |
| 2019-03-31 | $20.82M 10-Q · filed 2019-05-10 | |
| 2018-12-31 | $1.85M 10-K · filed 2020-03-16 | |
| 2018-09-30 | $37.77M 10-Q · filed 2018-11-09 | |
| 2018-06-30 | $43.93M 10-Q · filed 2018-08-09 | |
| 2018-03-31 | $41.65M 10-Q · filed 2018-05-10 | |
| 2017-12-31 | $52.57M 10-K · filed 2019-03-18 | |
| 2017-09-30 | $36.94M 10-Q · filed 2017-11-09 | |
| 2017-06-30 | $72.27M 10-Q · filed 2017-08-09 | |
| 2017-03-31 | $47.75M 10-Q · filed 2017-05-10 | |
| 2016-12-31 | $38.49M 10-K · filed 2018-03-16 | |
| 2016-09-30 | $36.63M 10-Q · filed 2016-11-09 | |
| 2016-06-30 | $35.34M 10-Q · filed 2016-08-09 | |
| 2016-03-31 | $44.56M 10-Q · filed 2016-05-10 | |
| 2015-12-31 | $56.85M 10-K · filed 2017-03-16 | |
| 2015-09-30 | $53.61M 10-Q · filed 2015-11-09 | |
| 2015-06-30 | $55.88M 10-Q · filed 2015-08-10 | |
| 2015-03-31 | $60.19M 10-Q · filed 2015-05-11 | |
| 2014-12-31 | $70.52M 10-K · filed 2016-03-15 | |
| 2014-09-30 | $69.26M 10-Q · filed 2014-11-06 | |
| 2014-06-30 | $72.37M 10-Q · filed 2014-08-11 | |
| 2014-03-31 | $75.49M 10-Q · filed 2014-05-12 | |
| 2013-12-31 | $81.28M 10-K · filed 2015-03-16 | |
| 2013-09-30 | $87.51M 10-Q · filed 2013-11-01 | |
| 2013-06-30 | $48.56M 10-Q · filed 2013-08-05 | |
| 2013-03-31 | $26.73M 10-Q · filed 2013-05-09 | |
| 2012-12-31 | $22.03M 10-K · filed 2015-03-16 | |
| 2012-09-30 | $29.13M 10-Q · filed 2012-11-14 | |
| 2012-06-30 | $33.82M 10-Q · filed 2012-08-08 | |
| 2012-03-31 | $13.45M 10-Q · filed 2012-05-15 | |
| 2011-12-31 | $19.13M 10-K · filed 2015-03-16 | |
| 2011-09-30 | -$44.64M 10-Q · filed 2011-11-14 | |
| 2010-12-31 | -$15.90M 10-K · filed 2013-03-18 | |
| 2009-12-31 | -$15.90M 10-K · filed 2014-03-14 | -$10.09M 10-Q · filed 2011-11-14 |
| 2008-12-31 | $5.00K 10-K · filed 2014-03-14 | -$6.50M 10-Q · filed 2011-11-14 |
| 2007-12-31 | -$2.75M 10-K · filed 2014-03-14 | -$2.75M 10-Q · filed 2011-11-14 |
| 2006-12-31 | -$123.00K 10-K · filed 2014-03-14 | |
| 2006-06-27 | $0.00 10-K · filed 2014-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ALX ONCOLOGY HOLDINGS INC (ALXO) | United States | $0.187B | -3.52 |
| PepGen Inc. (PEPG) | United States | $0.186B | -1.73 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| Zentalis Pharmaceuticals, Inc. (ZNTL) | United States | $0.196B | -2.48 |
| ORAMED PHARMACEUTICALS INC. (ORMP) | $0.199B | 1.13 | |
| Nkarta, Inc. (NKTX) | United States | $0.205B | -1.73 |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | United States | $0.166B | -1.34 |
| Minerva Neurosciences, Inc. (NERV) | United States | $0.165B | -0.66 |
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 |